Slate Path Capital LP

SEC CIK: 0001559706
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

EIGR holding history

Eiger BioPharmaceuticals, Inc. in every 13F filed by Slate Path Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EIGR overview All 13F holders of EIGR Full Q2 2026 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2022

Holdings of EIGR by Slate Path Capital LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−255,000−100.0%	Sold out	Holders
Q3 2022	255,000	$1.92M	0.1%	00.0%	Unchanged	Holders
Q2 2022	255,000	$1.61M	0.1%	00.0%	Unchanged	Holders
Q1 2022	255,000	$2.12M	0.1%	+255,000	New	Holders